
浏览全部资源
扫码关注微信
商丘市第一人民医院儿科
纸质出版日期:2022,
扫 描 看 全 文
黄蓉, 刘玉玲. 玉屏风颗粒联合丙酸氟替卡松治疗学龄期儿童支气管哮喘的疗效分析[J]. 保健医学研究与实践, 2022,19(6):31-34.
Huang Rong, Liu Yuling. Efficacy analysis of Yu Ping Feng granules combined with fluticasone propionate in the treatment of bronchial asthma in school-aged children[J]. Health Medicine Research and Practice, 2022,19(6):31-34.
黄蓉, 刘玉玲. 玉屏风颗粒联合丙酸氟替卡松治疗学龄期儿童支气管哮喘的疗效分析[J]. 保健医学研究与实践, 2022,19(6):31-34. DOI:
Huang Rong, Liu Yuling. Efficacy analysis of Yu Ping Feng granules combined with fluticasone propionate in the treatment of bronchial asthma in school-aged children[J]. Health Medicine Research and Practice, 2022,19(6):31-34. DOI:
目的 探讨玉屏风颗粒联合丙酸氟替卡松治疗学龄期儿童支气管哮喘的疗效及对患儿嗜酸性粒细胞(EOS)、白细胞介素-17(IL-17)水平的影响。方法 选取2019年3月—2021年3月商丘市某医院收治的90例支气管哮喘患儿为研究对象
采用简单随机分组法分为观察组和对照组
每组45例。对照组患儿采用丙酸氟替卡松治疗
观察组患儿在对照组基础上联合使用玉屏风颗粒治疗
2组患儿均持续治疗2周。比较2组患儿临床疗效、临床症状缓解时间
比较2组患儿治疗前后肺功能指标[第1秒用力呼气容积(FEV
1
)、最大呼气流速峰值(PEF)
用力呼气75%流速(FEF
75
)、最大呼气中期流速(MMEF
75/25
)]以及EOS、超敏C反应蛋白(hs-CRP)、IL-17水平
比较2组患儿治疗期间不良反应发生情况。结果 观察组患儿治疗总有效率为91.11%
高于对照组的75.56%
差异有统计学意义(χ
2
=3.920
P=0.048)。观察组患儿的喘息、肺部湿啰音以及咳嗽缓解时间均短于对照组
差异均有统计学意义(P
<
0.05)。治疗后
观察组患儿FEV
1
、PEF、FEF
75
、MMEF
75/25
指标水平均高于对照组
差异均有统计学意义(P
<
0.05)。治疗后
观察组患儿EOS、hs-CRP及IL-17水平均低于对照组
差异均有统计学意义(P
<
0.05)。观察组患儿治疗期间不良反应发生率为6.66%
低于对照组的8.88%
差异无统计学意义(P
>
0.05)。结论 玉屏风颗粒联合丙酸氟替卡松治疗可显著提高学龄期支气管哮喘患儿的临床疗效
改善患儿肺功能
降低机体炎症反应
且安全性高
值得在临床上推广使用。
Objective To investigate the efficacy of Yu Ping Feng granules combined with fluticasone propionate in the treatment of bronchial asthma in school-aged children and the effects on the levels of eosinophils(EOS) and interleukin-17(IL-17) in the children. Methods A total of 90 children with bronchial asthma admitted to a hospital in Shangqiu City from March 2019 to March 2021 were selected as subjects and assigned to observation and control groups using a simple randomized grouping method
with 45 cases in each group. Subjects in the control group were treated with fluticasone propionate
and subjects in the observation group with Yu Ping Feng granules in combination with fluticasone propionate
and subjects in both groups were treated for 2 weeks. The clinical efficacy and time to relief of clinical symptoms of the children in the two groups were compared. The pulmonary function indexes [forced expiratory volume in 1 s(FEV
1
)
peak expiratory flow(PEF) value
forced expiratory flow in 75% of forced vital capacity(FEF
75
)
Maximal midexpiratory flow between 75 and 25% of forced vital capacity(MMEF
75/25
)] and EOS
high-sensitivity C-reactive protein(hs-CRP)
and IL-17 levels of the children in the two groups were compared. The occurrence of adverse effects during treatment in the 2 groups of children was compared. Results The total effective rate of treatment for the children in the observation group was 91.11%
which was higher than that of the control group(75.56%)(χ~2=3.920
P=0.048). The children in the observation group had shorter wheezing
lung moist rale and cough relief time than those in the control group
and the differences were statistically significant(P
<
0.05). The levels of FEV
1
PEF
FEF
75
and MMEF
75/25
in the children in the observation group after treatment were higher than those in the control group
and the differences were statistically significant(P
<
0.05). The levels of EOS
hs-CRP and IL-17 in the children in the observation group after treatment were lower than those in the control group
and the differences were statistically significant(P
<
0.05). The incidence of adverse reactions during treatment was 6.66%in the children in the observation group
which was lower than that in the control group(8.88%)
and the difference was not statistically significant(P
>
0.05). Conclusion Yu Ping Feng granules in combination with fluticasone propionate can significantly improve the clinical efficacy
enhance the lung function and reduce the inflammatory response in school-aged children with bronchial asthma in a safe manner. These advantages justify a wider application of this therapy clinically.
玉屏风颗粒丙酸氟替卡松儿童支气管哮喘嗜酸性粒细胞白细胞介素-17
Yu ping feng granulesFluticasone propionateBronchial asthma in childrenEosinophilInterleukin-17
0
浏览量
28
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621